These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38703321)

  • 1. Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers.
    Du P; Long Y; Wang M; Huang Y; Wang Y; Chen X; Lin Y; Wu J; Shen J; Jia Y
    Cancer Chemother Pharmacol; 2024 Aug; 94(2):251-257. PubMed ID: 38703321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects.
    Hu L; Dou T; Sun Q; Tang L; Cai M; Qian W; Wang H
    Invest New Drugs; 2023 Apr; 41(2):276-283. PubMed ID: 36800130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open-label, two-period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers.
    Jiang X; Tao Y; Liu Y; Shi P; Li T; Sun F; Cao Y; Wang C
    Br J Clin Pharmacol; 2022 Mar; 88(3):1087-1093. PubMed ID: 34378245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers.
    Chen X; Yang F; Zhao J; Tang Q; Heng J; Deng J; Zhang J; Chen Y; Li K; Wang J
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):141-148. PubMed ID: 34851444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.
    Bai W; Sun X; Qiu B; Guo C; Song H; Hu Y; Zhang X; Yin P; Wang X; Dong Z
    Drug Des Devel Ther; 2024; 18():2273-2285. PubMed ID: 38895175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer.
    Moore K; Zhang ZY; Agarwal S; Burris H; Patel MR; Kansra V
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):497-503. PubMed ID: 29322231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of fluzoparib tablet formulation, an oral PARP inhibitor: effect of food on the pharmacokinetics and metabolism after oral dosing in healthy Chinese volunteers.
    Wu M; Li X; Sun J; Chen H; Ding Y
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):503-508. PubMed ID: 33535835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
    Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
    Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole interferes in the pharmacokinetics of fuzuloparib in healthy volunteers.
    Hu C; Zhang Y; Pei T; Liu P; Zhang L
    Cancer Chemother Pharmacol; 2023 Jun; 91(6):523-529. PubMed ID: 37166499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.
    Liu Y; Cheng J; Liang L; Qian W; Ou M; Zhang M; Wang Y; Wang Y; Peng K; Jia J
    PLoS One; 2023; 18(4):e0284576. PubMed ID: 37083730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
    Tomkinson H; McBride E; Martin P; Lisbon E; Dymond AW; Cantarini M; So K; Holt D
    Clin Ther; 2017 Nov; 39(11):2260-2275.e1. PubMed ID: 28985960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects.
    Cao B; Ma T; Zhang Y; Huang L; Lin H; Jiang H; Zhao Y; Geng Y; Yang Y; Cao S; Li J
    Invest New Drugs; 2024 Jun; 42(3):289-298. PubMed ID: 38602625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
    Kim HC; Yang E; Lee S; Oh J; Lee M; Lee C; Ha KS; Lee WS; Jang IJ; Yu KS
    Invest New Drugs; 2024 Feb; 42(1):80-88. PubMed ID: 38099989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
    Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
    Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers.
    Zhang Q; Kai J; Zhai Y; Xu N; Shentu J; Zhang Y; Liang Y; Wang Y; Wu L
    Br J Clin Pharmacol; 2022 Jan; 88(1):84-90. PubMed ID: 34033139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters.
    Wang Y; He Y; Li W; Li H; Tang L; Dai X; Pei Y; Gao L
    Drugs R D; 2024 Jun; 24(2):145-154. PubMed ID: 38644462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal
    Hu C; Lin Q; Liu C; Liu J; Chen X; Li X; Zhao G; Zhang L
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):793-801. PubMed ID: 33089408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.